Selinexor with low-dose dexamethasone for treating refractory multiple myeloma (terminated appraisal)

  • Technology appraisal
  • TA700
  • Published: 

This guidance has been updated and replaced by NICE technology appraisal guidance 970 and NICE technology appraisal guidance 974.